A Study of GFH925 in Patients With Advanced Solid Tumors With KRAS G12C Mutations
Clinical trial NCT05005234 · COMPLETED
Trial details
- NCT number
- NCT05005234
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-13
- Primary completion
- 2023-02-20
- Enrollment
- 334
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.